Medical research and development contract army sbir PH II proposal number A2-7668 titled, "nanostasis intravenous agent for traumatic hemorrhage control."
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0003
- Awardee
-
Critical Innovations LLC UEI Q611FJPN1AK5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,100,000
Award facts
- Opportunity
-
- HQ003419R0BAB Solicitation number
- Contract value 100% obligated
- $1,100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Inglewood, CA 90302, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $550,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $550,000 |
About this award
This is a firm fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,100,000.00, is for the development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control" as part of a Phase II SBIR effort. Critical Innovations LLC is an ISO certified, DCAA compliant medical research and development company that has been awarded over $10 million in federal contracts as a prime contractor under the SBIR program. The company has previously provided research, prototypes, and products to the Defense Health Agency, Army, and Air Force agencies, focusing on wound treatment, hemorrhage control devices, automated diagnosis and treatment systems, and specialized foam for burn wounds.
Quick answers
Who was awarded contract W81XWH20C0003?
W81XWH20C0003 was awarded to Critical Innovations LLC by Medical Command (Department of the Army) on December 9, 2019.
How much is contract W81XWH20C0003 worth?
The government has obligated $1,100,000 on W81XWH20C0003.
Was contract W81XWH20C0003 competed?
The extent of competition for W81XWH20C0003 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award